ADC Therapeutics SA

1.59
-0.17 (-9.66%)
At close: Mar 03, 2025, 3:59 PM
1.62
1.57%
After-hours: Mar 03, 2025, 06:50 PM EST

ADC Therapeutics SA Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 69.56M 209.91M 33.92M n/a 2.34M 1.14M 1.8M
Cost of Revenue 2.53M 4.58M 1.39M 1.97M 107.54M 118.09M 85.53M
Gross Profit 67.03M 205.33M 32.52M -1.97M -105.2M -116.95M -83.73M
Operating Income -165.99M -123.63M -261.72M -219.26M -119.4M -125.94M -91.67M
Interest Income 10.54M 17.97M 66K 832K 2.25M 2.86M 1.03M
Pretax Income -195.42M -154.66M -251.5M -245.96M -115.9M -122.87M -89.81M
Net Income -240.05M -155.8M -230.03M -246.29M -116.48M -123.1M -89.86M
Selling & General & Admin 105.89M 141.06M 136.24M 77.23M 13.81M 8.6M 7.81M
Research & Development 127.13M 187.9M 158M 142.03M 107.54M 118.31M 85.53M
Other Expenses n/a 14.58M 28.49M -46.4M 388K 166K 137K
Operating Expenses 233.01M 328.96M 294.24M 219.26M 121.74M 127.08M 93.47M
Interest Expense 46.33M 36.92M 18.34M 4.93M 156K n/a n/a
Selling & Marketing Expenses 57.46M 69.05M 64.78M 22.1M n/a n/a n/a
Cost & Expenses 235.54M 333.54M 295.64M 219.26M 121.74M 127.08M 93.47M
Income Tax 39.11M 1.14M -21.48M 327K 582K 224K 48K
Shares Outstanding (Basic) 81.71M 78.15M 76.75M 65.41M 66.87M 53.83M 58.85M
Shares Outstanding (Diluted) 81.71M 78.15M 76.75M 65.41M 66.87M 53.83M 58.85M
EPS (Basic) -2.94 -1.99 -3 -3.77 -1.74 -2.29 -1.53
EPS (Diluted) -2.94 -1.99 -3 -3.77 -1.74 -2.29 -1.53
EBITDA -146.76M -108.06M -223.72M -219.26M -114.1M -122.36M -91.33M
Depreciation & Amortization 3.27M 2.39M 2.63M 1.97M 1.65M 513K 341K